Pharmaceuticals

Digital Therapeutics For Fibromyalgia Industry Poised for Rapid Growth, Forecast to Touch $3.07 Billion by 2030 at 20.8% CAGR

February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the digital therapeutics for fibromyalgia market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Digital Therapeutics For Fibromyalgia Market?

The digital therapeutics for fibromyalgia market has experienced substantial growth in recent years. It is projected to increase from $1.19 billion in 2025 to $1.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.1%. Historically, this market expansion has been driven by increasing awareness regarding fibromyalgia management needs, greater acceptance of digital health solutions, enhanced smartphone penetration within healthcare, the broadening of telehealth services, and the limitations inherent in traditional pain management approaches.

The digital therapeutics for fibromyalgia market size is projected to experience substantial growth in the coming years. It is forecast to expand to $3.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.8%. This expansion during the forecast period is primarily driven by the escalating demand for personalized chronic pain management, the increasing integration of AI-driven therapy optimization, the broadening of remote care reimbursement models, a heightened focus on data-driven treatment personalization, and strengthened collaboration between clinicians and digital health providers. Key trends anticipated within the forecast period encompass the wider adoption of symptom-tracking mobile therapies, the rising use of personalized digital care plans, the growing integration of wearables with therapeutic platforms, the expansion of remote patient monitoring programs, and an enhanced emphasis on patient engagement and adherence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29026&type=smp

Which Drivers Are Supporting The Rise Of The Digital Therapeutics For Fibromyalgia Market?

The expansion of the digital therapeutics for fibromyalgia market is anticipated to be driven by increasing recognition of digital health solutions. These solutions encompass software-enabled tools and services, such as patient applications, portals, and virtual care platforms, designed to offer information, monitoring, and therapeutic interventions through digital avenues. The rise in awareness regarding digital health solutions stems from government-led promotional efforts and the widespread adoption of official health applications, which normalize access to healthcare online. Digital therapeutics specifically for fibromyalgia capitalize on this heightened awareness by engaging patients through these well-known digital channels, thereby simplifying the initiation and consistent use of app-based cognitive behavioral therapy, pacing, and sleep regimens, while simultaneously enabling supervision by clinicians. For example, data from December 2023, reported by the National Health Service, a UK-based government department, indicated that digital health app users in the UK surged to 33.6 million, an increase from 16.8 million in 2022, with monthly logins experiencing a 54% rise from 16.8 million to 25.8 million. Consequently, the expanding public knowledge of digital health solutions is a key factor propelling the digital therapeutics for fibromyalgia market.

What Leading Segments Are Studied In The Digital Therapeutics For Fibromyalgia Market?

The digital therapeutics for fibromyalgia market covered in this report is segmented –

1) By Product Type: Software Applications, Devices, Platforms

2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types

3) By Distribution Channel: Online, Offline

4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications

5) By End-User: Hospitals, Clinics, Homecare, Other End-Users

Subsegments:

1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications

2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices

3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms

Which Competitive Trends Are Impacting The Structure Of The Digital Therapeutics For Fibromyalgia Market?

Key companies operating in the digital therapeutics for fibromyalgia market are prioritizing technological advancements, such as computerized behavioral therapy devices, to deliver proven interventions that improve pain management, reduce fatigue, enhance sleep quality, and support mental health, all through scalable, patient-centric digital platforms. A computerized behavioral therapy device refers to a software-based digital platform or application that delivers structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, often using interactive modules, exercises, and real-time feedback to manage symptoms of conditions such as fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). It delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial in the lancet reporting significant clinical improvements. This is delivered via smartphone (iOS or Android), and meets patients in-app for convenient, at-home therapy.

Which Key Players Are Driving Competition In The Digital Therapeutics For Fibromyalgia Market?

Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-for-fibromyalgia-global-market-report

Which Region Is Projected To Lead The Digital Therapeutics For Fibromyalgia Market During The Forecast Period?

North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for fibromyalgia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Digital Therapeutics For Fibromyalgia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29026&type=smp

Browse Through More Reports Similar to the Global Digital Therapeutics For Fibromyalgia Market 2026, By The Business Research Company

Fibromyalgia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Digital Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

Digital Health In Neurology Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-health-in-neurology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795